- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: potentiation
Total 60 results
-
Ruijin HospitalRecruitingGeneral Anesthesia | Electrophysiology | Consciousness, Loss of | Deep Brain Stimulation SurgeryChina
-
Centre Hospitalier du RouvrayUniversity Hospital, Rouen; Centre Hospitalier Sainte Anne, ParisNot yet recruiting
-
Universiti Putra MalaysiaRecruiting
-
Massachusetts General HospitalFoundation for OCD ResearchRecruitingObsessive-Compulsive DisorderUnited States
-
Lakshmi Nayak, MDKazia Therapeutics LimitedRecruitingPrimary Central Nervous System Lymphoma | Non-Hodgkin Lymphoma of Extranodal SiteUnited States
-
Sheba Medical CenterRecruitingNewly Diagnosed Glioblastoma Who Underwent at Least Partial Resection of the Tumor SurgicallyIsrael
-
Brennan ThompsonWithdrawnPost Activation PotentiationUnited States
-
Il-Yang Pharm. Co., Ltd.CompletedDrug Interaction PotentiationKorea, Republic of
-
Il-Yang Pharm. Co., Ltd.CompletedDrug Interaction PotentiationKorea, Republic of
-
Universidade do PortoWithdrawn
-
Diakonhjemmet HospitalUniversity of Oslo; Diakonhjemmet Hospital Pharmacy; Diakonhjemmet FoundationCompletedDrug-Related Side Effects and Adverse Reactions | Drug Interaction Potentiation | Medication Compliance | Remission | Medicinal Substance; Adverse EffectNorway
-
Science and Research Centre KoperUniversity of LjubljanaCompletedIschemia | Placebo - ControlSlovenia
-
Centre Hospitalier Universitaire VaudoisTerminatedChronic PainSwitzerland
-
Cairo UniversityUniversity of PittsburghCompleted
-
University of EdinburghNHS Lothian; Chief Scientist Office of the Scottish GovernmentCompletedHeart Disease | Vascular DiseaseUnited Kingdom
-
University of Wisconsin, MadisonNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Completed
-
F-star Therapeutics, Inc.PRA Health SciencesCompletedDrug Interaction PotentiationNetherlands
-
University Hospital, ToursCompletedStress Disorders, Post-Traumatic
-
Walter K. KraftMerck Sharp & Dohme LLCCompletedLatent Tuberculosis | Human Immunodeficiency Virus | Drug Interaction Potentiation | Rifamycins Causing Adverse Effects in Therapeutic UseUnited States
-
Genelex CorporationHarding UniversityCompletedDrug Interaction Potentiation | Adverse Drug Events | Adverse Drug Reactions | Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant | Poor Metabolizer Due to Cytochrome p450 CYP2C19 Variant | Drug Metabolism, Poor, CYP2D6-RELATED | Drug Metabolism, Poor, CYP2C19-RELATED | Cytochrome P450 Enzyme... and other conditionsUnited States
-
University of ManitobaUniversity of CalgaryTerminated
-
Masonic Cancer Center, University of MinnesotaCompletedHead and Neck Cancer | Head and Neck Squamous Cell CarcinomaUnited States
-
Emory UniversityCompletedPosttraumatic Stress DisorderUnited States
-
National Taiwan University HospitalCompletedDrug Interaction PotentiationTaiwan
-
University of Wisconsin, MadisonNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Completed
-
Akebia TherapeuticsCompletedDrug Interaction PotentiationCanada
-
Akebia TherapeuticsCompletedDrug Interaction PotentiationCanada
-
Akebia TherapeuticsCompletedPharmacokinetics | Drug Interaction PotentiationCanada
-
Akebia TherapeuticsCompletedDrug Interaction PotentiationCanada
-
National Cheng-Kung University HospitalMerck Sharp & Dohme LLCCompleted
-
Amsterdam UMC, location VUmcUnknownVentricular Tachycardia | Post-extrasystolic Potentiation (PESP)Netherlands
-
Best Answer for Cancer FoundationWithdrawn
-
Hospices Civils de LyonCompleted
-
University of Sao Paulo General HospitalInCor Heart InstituteCompletedCoronary Artery Disease | Drug Interaction Potentiation
-
Corcept TherapeuticsCompletedHealthy | Drug Interaction PotentiationUnited States
-
Peking University People's HospitalUnknown
-
LEO PharmaCompletedDrug Interaction PotentiationGermany
-
Assistance Publique - Hôpitaux de ParisCancer Research and Personalized Medicine (Carpem); Laboratoire d'excellence...Unknown
-
Jamia Millia IslamiaCompleted
-
Dr. R. Pfleger Chemische Fabrik GmbHCompletedPharmacokinetics | Drug Interaction Potentiation | Inhibition Enzyme
-
Medical University of ViennaCompletedMyocardial Infarction | Drug Interaction PotentiationAustria
-
Genelex CorporationUniversity of UtahCompletedDrug Interaction Potentiation | Adverse Drug Events | Adverse Drug Reactions | Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant | Drug Metabolism, Poor, CYP2D6-RELATED | Drug Metabolism, Poor, CYP2C19-RELATED | Cytochrome P450 Enzyme Deficiency | Cytochrome P450 CYP2D6 Enzyme Deficiency | Cytochrome... and other conditionsUnited States
-
Il-Yang Pharm. Co., Ltd.Severance HospitalCompletedDrug Interaction PotentiationKorea, Republic of
-
Nivalis Therapeutics, Inc.Davita Clinical ResearchCompletedDrug Interaction PotentiationUnited States
-
Dr Alexander McIntyre Inc.CompletedMajor Depression With Comorbid Anxiety SymptomsCanada
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Ovarian Carcinoma | Fallopian Tube Carcinoma | Primary Peritoneal Carcinoma | Stage IV Ovarian Cancer | Stage III Ovarian CancerUnited States
-
SK Chemicals Co., Ltd.CompletedDrug Interaction Potentiation
-
SK Chemicals Co., Ltd.CompletedDrug Interaction Potentiation
-
OncotherapeuticsWithdrawnStage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Plasma Cell NeoplasmUnited States
-
Constantine A. KotsanisBest Answer for Cancer FoundationUnknown